News • Blogs • Videos •
Forward to Friend
NSP Logo
Nicotine Science and Policy
Daily Digest - Thursday, 30 June 2016

More people turning to vaping as tobacco price rises

A Northland retailer selling e-cigarettes is "astounded" by the growth in sales since tobacco prices increased 10 per cent on January 1. People puffing on the electronic devices, or "vaping" as the practice was known, were becoming a common sight around Northland with the retailer - who spoke anonymously - describing the cigarette substitutes as "the best thing I've ever sold".


E-cigarette use among college students: Helpful aid or risky enabler?

The purpose of this study was to examine e-cigarette use and the relation of such use with gender, race/ethnicity, traditional tobacco use, and heavy drinking. A sample of 599 college students enrolled in General Psychology at a state university completed a self-report questionnaire. Twenty-nine percent of students reported prior use of e-cigarettes, with 14% reporting use in the past 30 days. [...]


Exhaled aerosol particles e-cigs & cigarettes

Dainius Martuzevicius from the Kaunus University of Technology Lithuania - Characterisation of the dynamic properties of exhaled aerosol particles following use of electronic and conventional cigarettes.


The FDA's Deeming Rule On Vapor Products Must Be Challenged

Legal challenges to the U.S. Food and Drug Administration’s (FDA) final deeming rule on vapor products are mounting, with lawsuits focusing on various aspects of the regulations, including claims ranging from violations of the Regulatory Flexibility Act and Administrative Procedure Act, to infringement of freedom of speech under the First Amendment and encroachment of the Fifth Amendment’s due process clause.


Smoking Cessation Drugs Pose Little Neuropsychiatric Risk

The smoking cessation medications varenicline and bupropion do not increase the risk of moderate-to-severe neuropsychiatric adverse events, including among smokers with stable psychiatric disorders, according to the largest trial of pharmacotherapy for smoking cessation to date [...] The study is also the first comparative efficacy trial of the 3 first-line smoking cessation drugs.


Perceptual and experiential factors in switching to e-cigarettes

Dr Christopher Russell from the Centre for Substance Use Research, UK - Perceptual and experiential factors explaining how 4,235 individuals initiated and established e-cigarette use in place of cigarette smoking.


Visit "" for more news
Copyright © 2016 Nicotine Science and Policy, All rights reserved.

unsubscribe from this list    update subscription preferences 

Email Marketing Powered by MailChimp